Infectious Diseases
August 15, 2022
ROCHESTER, Minn. — Mayo Clinic researchers say the monoclonal antibody bebtelovimab, already authorized by the Food and Drug Administration for emergency use on the omicron[...]
February 10, 2016
February 10, 2016
February 5, 2016
February 4, 2016
February 1, 2016
January 29, 2016
January 29, 2016
January 28, 2016
January 27, 2016
January 19, 2016
January 19, 2016
Explore more topics
Sign up
Mayo Clinic Connect
An online patient support community